Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data by M.J. Emmett, J.C.F. Quintanilha, R.P. Graf, G. Li, H. Tukachinsky, A.B. Schrock, S. Morley, V.A. Fisher, G.R. Oxnard, C.H. Lieu, P.A. Myer, S.J. Klempner

Get full text

Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel study by S.J. Klempner, R.A. Pazo-Cid, S. Lonardi, L. Swanson, M.J. Arango, P. Enzinger, A.H. Ko, G.M. Vaccaro, K. Yamaguchi, A. Saeed, K.-W. Lee, K. Shitara, D. Ilson, J.A. Ajani, R. Fuldeore, S. Braun, M.S. Broder, M.A. Shah

Get full text

DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B by Keun-Wook Lee, Devalingam Mahalingam, Byoung Yong Shim, In-Ho Kim, Do-Youn Oh, Hope Uronis, Sun Jin Sym, Mohamad Sonbol, Khaldoun Almhanna, Mohamedtaki A. Tejani, Beodeul Kang, Michael H. Kagey, Melissa Stilian, Calvin Jia, Cynthia A. Sirard, Jaffer A. Ajani, Samuel J. Klempner

Get full text

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types by Vivek Subbiah, Samuel J Klempner, Neeraj Agarwal, David P Carbone, Amit Mahipal, Shilpa Gupta, David Fabrizio, Jeffrey S Ross, Gerald Li, David R Gandara, Miles C Andrews, Jonathan W Riess, Ramez N Eskander, Ryon P Graf, Geoffrey R Oxnard, Sarah Sammons, Jeremy Snider, Lilia Bouzit, Cheryl Cho-Phan, Megan Price, Julia C F Quintanilha, Richard Sheng Poe Huang

Get full text